Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

James K. Kirklin, Rongbing Xie, Jennifer Cowger, Theo M.M.H. de By, Takeshi Nakatani, Stephan Schueler, Rhiannon Taylor, Jenny Lannon, Paul Mohacsi, Jan Gummert, Daniel J. Goldstein, Kadir Caliskan, Margaret M. Hannan

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.

Original languageEnglish (US)
JournalJournal of Heart and Lung Transplantation
DOIs
StateAccepted/In press - Jan 1 2018

Keywords

  • Adverse events
  • IMACS
  • International Society for Heart and Lung Transplantation
  • Mechanical circulatory support
  • Outcomes
  • Risk factors
  • Ventricular assist devices

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint Dive into the research topics of 'Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry'. Together they form a unique fingerprint.

  • Cite this

    Kirklin, J. K., Xie, R., Cowger, J., de By, T. M. M. H., Nakatani, T., Schueler, S., Taylor, R., Lannon, J., Mohacsi, P., Gummert, J., Goldstein, D. J., Caliskan, K., & Hannan, M. M. (Accepted/In press). Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2018.01.1294